Sign Up to like & get
recommendations!
1
Published in 2022 at "Archiv der Pharmazie"
DOI: 10.1002/ardp.202200004
Abstract: For the first time, compounds developed from the 1,2,3‐triazole scaffold were evaluated as novel drugs to treat triple‐negative breast cancer (TNBC). Four organic salts were idealized as nonclassical bioisosteres of miltefosine, which is used in…
read more here.
Keywords:
triple negative;
toxicity;
triazole;
dhmtac ... See more keywords